Athersys (FRA:4LSA) Accumulated other comprehensive income (loss) : €1.13 Mil (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Athersys Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Athersys's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2023 was €1.13 Mil.

Athersys's quarterly Accumulated other comprehensive income (loss) stayed the same from Mar. 2023 (€0.00 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Sep. 2023 (€1.13 Mil).

Athersys Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Athersys's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athersys Accumulated other comprehensive income (loss) Chart

Athersys Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

Athersys Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-	-	-	-	1.13

Athersys Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Athersys Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Athersys's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Athersys (FRA:4LSA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Athersys Inc (FRA:4LSA) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

ATHXQ:USA

Address

3201 Carnegie Avenue, Cleveland, OH, USA, 44115-2634

Website

https://www.athersys.com

Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Athersys (FRA:4LSA) Headlines

No Headlines